Heart HealthResearch PaperPaywall

Scientists Discover How Blood Flow Patterns Trigger Artery Disease Through Enzyme Switch

New research reveals how disturbed blood flow activates a specific protein pathway that leads to atherosclerosis development.

Sunday, March 29, 2026 0 views
Published in Circulation
Scientific visualization: Scientists Discover How Blood Flow Patterns Trigger Artery Disease Through Enzyme Switch

Summary

Scientists have identified a key molecular mechanism explaining how disturbed blood flow patterns trigger atherosclerosis. The study found that irregular blood flow reduces a protective protein called KLF2, which normally suppresses DAPK2. When DAPK2 increases, it modifies another enzyme (PKM2) that moves into cell nuclei and activates inflammatory genes. This cascade promotes plaque formation in arteries. Mice engineered to block this pathway showed significant protection against atherosclerosis, suggesting potential therapeutic targets for preventing cardiovascular disease.

Detailed Summary

This groundbreaking research explains how blood flow patterns directly influence artery health at the molecular level, offering new insights into preventing cardiovascular disease. Understanding this mechanism could lead to targeted therapies for atherosclerosis, a leading cause of heart attacks and strokes.

Researchers studied how oscillatory shear stress from disturbed blood flow affects endothelial cells lining arteries. They used multiple approaches including genome analysis, mass spectrometry, and genetically modified mice to trace the complete molecular pathway.

The team discovered that disturbed flow reduces KLF2, a protective protein that normally suppresses DAPK2. When DAPK2 increases, it phosphorylates PKM2 at a specific site, causing PKM2 to form dimers and migrate to cell nuclei. Nuclear PKM2 then activates inflammatory genes like VCAM-1 and ICAM-1, promoting atherosclerosis. Mice lacking endothelial DAPK2 showed dramatically reduced plaque formation.

This pathway represents a direct link between mechanical forces and genetic responses in blood vessels. The findings suggest that targeting DAPK2 or preventing PKM2 phosphorylation could protect against atherosclerosis. Since disturbed flow occurs naturally at artery branch points and curves, this mechanism helps explain why plaques develop in predictable locations. The research also validates PKM2 phosphorylation as a potential biomarker for cardiovascular risk assessment and therapeutic monitoring.

Key Findings

  • Disturbed blood flow reduces protective KLF2 protein, increasing harmful DAPK2 levels
  • DAPK2 modifies PKM2 enzyme, causing it to activate inflammatory genes in artery cells
  • Blocking this pathway in mice prevented atherosclerosis development significantly
  • PKM2 phosphorylation could serve as biomarker for cardiovascular disease risk

Methodology

Researchers used genome-wide analysis, mass spectrometry, and genetically modified Apoe-/- mice with endothelial-specific gene modifications. Multiple atherosclerosis models included carotid artery ligation and Western diet feeding protocols.

Study Limitations

Study conducted primarily in mouse models with limited human validation. Long-term safety and efficacy of targeting this pathway in humans requires further investigation.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.